Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Gynecol Endocrinol ; 32(7): 534-7, 2016 Jul.
Article in English | MEDLINE | ID: mdl-26829445

ABSTRACT

OBJECTIVE: The objective of this study is to compare the combination of dehydroepiandrosterone (DHEA) and coenzyme Q10 (CoQ10) (D + C) with DHEA alone (D) in intrauterine insemination (IUI) and in vitro fertilization (IVF) cycles among patients with decreased ovarian reserve. METHODS: We retrospectively extracted data from patients charts treated by DHEA with/without CoQ10 during IUI or IVF between February 2006 and June 2014. Prestimulation parameters included age, BMI, day 3 FSH and antral follicular count (AFC). Ovarian response parameters included total gonadotropins dosage, peak serum estradiol, number of follicles > 16 mm and fertilization rate. Clinical outcomes included clinical and ongoing pregnancy rates. RESULTS: Three hundred and thirty IUI cycles involved D + C compared with 467 cycles of D; 78 IVF cycles involved D + C and 175 D. In both IUI and IVF, AFC was higher with D + C compared with D (7.4 ± 5.7 versus 5.9 ± 4.7, 8.2 ± 6.3 versus 5.2 ± 5, respectively, p < 0.05). D + C resulted in a more follicles > 16 mm during IUI cycles (3.3 ± 2.3 versus 2.9 ± 2.2, respectively, p = 0.01), while lower mean total gonadotropin dosage was administered after D + C supplementation compared with D (3414 ± 1141 IUs versus 3877 ± 1143 IUs respectively, p = 0.032) in IVF cycles. Pregnancy and delivery rates were similar for both IUI and IVF. CONCLUSION: D + C significantly increases AFC and improves ovarian responsiveness during IUI and IVF without a difference in clinical outcome.


Subject(s)
Dehydroepiandrosterone/pharmacology , Fertilization in Vitro/methods , Gonadal Steroid Hormones/pharmacology , Insemination, Artificial/methods , Outcome Assessment, Health Care , Ovarian Reserve/drug effects , Ovulation Induction/methods , Ubiquinone/analogs & derivatives , Vitamins/pharmacology , Adult , Dehydroepiandrosterone/administration & dosage , Drug Therapy, Combination , Female , Gonadal Steroid Hormones/administration & dosage , Humans , Pregnancy , Retrospective Studies , Ubiquinone/administration & dosage , Ubiquinone/pharmacology , Vitamins/administration & dosage
2.
Semin Ophthalmol ; 25(5-6): 275-82, 2010.
Article in English | MEDLINE | ID: mdl-21091012

ABSTRACT

PURPOSE: The goal of this study was to review, evaluate, and perform a meta-analysis on the current literature that reports rates of postoperative endophthalmitis after small gauge transconjunctival sutureless vitrectomy (TSV) and compare it to 20-gauge pars plana vitrectomy (20G PPV). METHODS: We performed an extensive review of the current literature. We included only large comparative institutional reviews. Meta-analysis of these reviews was performed. RESULTS: We found six large retrospective comparative cases series on the 25-gauge (25G) TSV as compared to 20G PPV. The test for homogeneity for the meta-analysis indicates that the studies are not homogeneous and therefore the evidence is tentative. CONCLUSION: We cannot conclude that 25G TSV has a higher rate of postoperative endophthalmitis compared to the 20G PPV. Future retrospective or prospective trials need to take into consideration multiple factors.


Subject(s)
Endophthalmitis/etiology , Microsurgery/adverse effects , Postoperative Complications , Suture Techniques , Vitrectomy/adverse effects , Conjunctiva , Endophthalmitis/epidemiology , Humans , Risk Assessment , Vitreous Body/surgery
3.
Semin Ophthalmol ; 24(2): 70-6, 2009.
Article in English | MEDLINE | ID: mdl-19373689

ABSTRACT

While angiogenesis inhibitors are already widely used to treat retinal disease in adults, only limited reports are currently available for the use of anti-VEGF in pediatric vitreoretinal diseases such as retinopathy of prematurity, Coats' disease, familial exudative vitreoretinopathy and retinopathy of incontinentia pigmenti. The limited trials of anti-VEGF therapy for pediatric vitreoretinal diseases are promising, although more extensive controlled trials will be needed to confirm their safety and efficacy. This paper will examine the current evidence for use of anti-VEGF therapy in a number of pediatric vitreoretinal disorders and describe a case of anti-VEGF therapy in retinopathy of incontinentia pigmenti.


Subject(s)
Eye Diseases/drug therapy , Retinal Diseases/drug therapy , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Vitreous Body , Angiogenesis Inhibitors/therapeutic use , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Bevacizumab , Eye/blood supply , Humans , Incontinentia Pigmenti/complications , Infant , Infant, Newborn , Male , Neovascularization, Pathologic/drug therapy , Neovascularization, Pathologic/etiology , Preoperative Care , Retinal Detachment/etiology , Retinal Detachment/surgery , Retinal Vessels/abnormalities , Retinopathy of Prematurity/drug therapy , Vitreous Body/blood supply
4.
Microsc Res Tech ; 72(3): 182-6, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19189372

ABSTRACT

The intermediate voltage electron microscope-tandem user facility in the Electron Microscopy Center at Argonne National Laboratory is described. The primary purpose of this facility is electron microscopy with in situ ion irradiation at controlled sample temperatures. To illustrate its capabilities and advantages a few results of two outside user projects are presented. The motion of dislocation loops formed during ion irradiation is illustrated in video data that reveals a striking reduction of motion in Fe-8%Cr over that in pure Fe. The development of extended defect structure is then shown to depend on this motion and the influence of nearby surfaces in the transmission electron microscopy thin samples. In a second project, the damage microstructure is followed to high dose (200 dpa) in an oxide dispersion strengthened ferritic alloy at 500 degrees C, and found to be qualitatively similar to that observed in the same alloy neutron irradiated at 420 degrees C.


Subject(s)
Ferric Compounds/radiation effects , Microscopy, Electron, Transmission , Alloys/chemistry , Alloys/radiation effects , Ferric Compounds/chemistry , Microscopy, Electron, Transmission/instrumentation , Nanostructures/chemistry , Nanostructures/radiation effects , Nanostructures/ultrastructure , Surface Properties , Temperature
7.
Semin Ophthalmol ; 21(3): 143-50, 2006.
Article in English | MEDLINE | ID: mdl-16912012

ABSTRACT

von Hippel-Lindau disease is a multisystem familial cancer syndrome that commonly manifests in the eye as retinal capillary hemangiomas. As the earliest manifestation of the disease, these benign hamartomas can lead to secondary visual loss. Their typical clinical characteristics can lead to accurate diagnosis and appropriate treatment with either laser photocoagulation or cryotherapy enhancing one's probability of preserving vision before becoming symptomatic. Accurate diagnosis can also lead to surveillance of the various other organ systems involved in the disease such as the CNS, kidneys, adrenal glands and pancreas. This will also enable the clinician to provide genetic counseling for patients regarding the lifelong manifestations of this disease.


Subject(s)
Hemangioma, Capillary/diagnosis , Retinal Neoplasms/diagnosis , Retinal Vessels/pathology , von Hippel-Lindau Disease/diagnosis , Diagnosis, Differential , Hemangioma, Capillary/surgery , Humans , Laser Coagulation , Retinal Neoplasms/surgery , von Hippel-Lindau Disease/surgery
10.
Semin Ophthalmol ; 17(3-4): 153-61, 2002.
Article in English | MEDLINE | ID: mdl-12759845

ABSTRACT

Endophthalmitis following routine cataract surgery is a rare but potentially devastating complication resulting in severe vision loss. Various prophylaxis treatments have been tried. However, none have been demonstrated to completely eliminate the risk. The Endophthalmitis Vitrectomy Study (EVS) helped establish clinical guidelines in the treatment of post-operative endophthalmitis in a prospective, randomized, multicenter trial. The strength and limitation of the study will be discussed as well as the current knowledge of the pharmacokinetics of intravitreous injection of antibiotics. Additionally, the common pathologic organisms, the use of antibiotic therapy, steroids, and vitrectomy will be discussed.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Endophthalmitis/drug therapy , Eye Infections, Bacterial/drug therapy , Postoperative Complications/drug therapy , Anti-Bacterial Agents/pharmacokinetics , Antibiotic Prophylaxis , Cataract Extraction/adverse effects , Endophthalmitis/microbiology , Eye Infections, Bacterial/etiology , Humans , Postoperative Complications/microbiology , Practice Guidelines as Topic
SELECTION OF CITATIONS
SEARCH DETAIL
...